Organon OGN
NYSE OGN
$13.64 -0.03 (-0.26%)
As of: Sep 10, 2026 · 3:59 PM EDT

Organon (OGN) Assets Average (2021 - 2026)

Organon (OGN) posted Assets Average of $13.1 billion for Q2 2026, up 1.2% on a QoQ basis from $12.9 billion in Q1 2026, and down 1.81% year-over-year from $13.3 billion in Q2 2025.

Analysis

Organon (OGN) Assets Average (2021 - 2026) Analysis & Trends

Organon has reported Assets Average for 6 years, with the latest figure at $13.1 billion in Q2 2026.

  • On a quarterly basis, Assets Average fell 1.81% year-over-year to $13.1 billion in Q2 2026; TTM through Jun 2026 was $13.1 billion, a 1.81% decrease from a year earlier, with the FY2025 full-year figure at $13.0 billion, up 3.22% from the prior year.
  • Assets Average was $13.1 billion for Q2 2026 at Organon, up from $12.9 billion in the prior quarter.
  • The five-year high for Assets Average was $13.5 billion in Q3 2025, with the low at $10.5 billion in Q3 2022.
  • Average Assets Average over 5 years is $12.0 billion, with a median of $12.0 billion recorded in 2024.
  • The sharpest annual moves came in 2022 and 2024: Assets Average decreased 5.36% in 2022, then climbed 13.26% in 2024.
  • Over 5 years, Assets Average stood at $10.7 billion in 2022, then gained by 7.84% to $11.5 billion in 2023, then advanced by 12.06% to $12.9 billion in 2024, then gained by 2.19% to $13.2 billion in 2025, then decreased by 0.93% to $13.1 billion in 2026.
  • The last three Assets Average figures came in at $13.1 billion (Q2 2026), $12.9 billion (Q1 2026), and $13.2 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 200.98 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn 135.79 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 129.24 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 120.28 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 204.57 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 149.95 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn - 3.29 Bn
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 7.61 Bn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 6.97 Bn
10 Organon 3.58 Bn 2.45 Bn 847.00 Mn 13.09 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.09 Bn
Mar 31, 2026 12.93 Bn
Dec 31, 2025 13.21 Bn
Sep 30, 2025 13.53 Bn
Jun 30, 2025 13.33 Bn
Mar 31, 2025 13.13 Bn
Dec 31, 2024 12.93 Bn
Sep 30, 2024 12.45 Bn
Jun 30, 2024 12.02 Bn
Mar 31, 2024 11.97 Bn
Dec 31, 2023 11.54 Bn
Sep 30, 2023 11.00 Bn
Jun 30, 2023 10.87 Bn
Mar 31, 2023 10.86 Bn
Dec 31, 2022 10.70 Bn
Sep 30, 2022 10.53 Bn
Jun 30, 2022 10.61 Bn
Mar 31, 2022 10.64 Bn
Dec 31, 2021 11.01 Bn
Sep 30, 2021 11.12 Bn